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Changing healthcare systems in Asia  
 
This paper has been commissioned by Public Services International (PSI) to inform discussions at the Asia 
meeting of PSI affiliates to be held 14-17 December 2004. 
1. Aim/ objectives 
1.1. Aim 
 To provide a regional profile of changes in healthcare systems in Asia 
1.2. Objectives 
 To identify the main themes emerging in the commercialisation of health services in Asia 
 To outline the main organisational players 
 To outline key regional developments    
 To outline multinational healthcare company developments in Asia 
 To outline trade union action   
 
The paper will be structured in six sections: 
 Main themes of commercialisation 
 Key players 
 Regional developments 
 Companies 
 Trade union action 
 Conclusion 
 
2. Main themes 
 
Commercialisation of healthcare is a process that has been taking place in many countries over the past 
decade.  It affects the way in which healthcare is delivered and the pay and working conditions of health 
workers.  There are many dimensions of commercialisation, which may be adopted at different times.  Some 
examples are: the corporatisation of public sector healthcare institutions, the establishment of public-private 
partnerships, the changing role of the public sector as a provider of healthcare, the expansion of health 
insurance, and the development of medical tourism.  These will be outlined in the following pages. 
 
2.1. Corporatisation 
The development of health care institutions within the public sector that operate under business principles, 
often part of wider organisational restructuring, has been called “corporatisation”. This is taking place in 
countries throughout the world. 1 When introduced over a decade ago, the process was considered a first step 
towards the privatisation of health care services. It was assumed that once an institution operated like a 
business, it could be taken over by the private sector.  However with the formal takeover by the private 
sector, corporatisation is having a major impact on how the public healthcare sector operates, in many cases 
making the boundaries between public and private sector unclear.    
 
In Singapore, the government introduced a process of corporatisation to its public sector hospitals but this 
has not led to hospitals moving into the private sector.  Some have become successful in competing with the 
private sector. One of the major private sector healthcare companies based in Singapore, Parkway Holdings, 
has found that the corporatised public health sector has often an unexpectedly competitive edge, with 
government hospitals having newer facilities, cheaper prices and also car parks 2 
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Trade unions interviews in Malaysia showed that corporatisation of public hospitals, in the context of 
competition with the private sector, has had immediate effects on the workforce through efforts to control 
labour costs by contracting out services, sacking staff and increasing workloads.  An illustration of how the  
public and private sectors interface can be seen in the requirement for staff to work in both the public sector 
part of the hospital and the private patients‟ wing, resulting in health workers in the public sector wards 
covering for colleagues in the private sector wing or health workers working double shifts.  Types of 
contracts have been changed to make staff more “flexible”, and staff reductions are affecting particularly 
those aged over 45. Within hospitals operating under business principles, divisions emerge between high 
income and low income departments. Performance related pay also breaks down national pay agreements 
into individually negotiated contracts. The result is deepening divisions between different groups of health 
workers and different hospital departments in what is already a highly stratified sector.3   
 
2.2. Health insurance  
One of the aims of health sector reform is to increase the role of private health insurance in the financing of 
health care.  This is supported by the World Bank promotion of a model of basic public services for low 
income groups and private health insurance for middle income groups (see Section 2.1). 
 
Health insurance is targeted at middle income groups often portrayed as a “modern” way to pay for health 
care.  The introduction of co-payments for drugs and certain types of treatment in the public sector can also 
lead people to taking out private health insurance to cover these costs. In other cases, the quality of public 
health services deteriorates so much that people begin to use private sector providers, eventually funded by 
health insurance.   
 
In Asia, global insurance companies are beginning to enter national markets.  Multinational healthcare 
companies are aware that an adequate system of health insurance is needed if people are to pay for healthcare 
and enable private healthcare companies to expand their markets.  
 
Governments are also reviewing systems of financing healthcare.  Malaysia has a tax based healthcare 
system with a parallel private health insurance sector, which has expanded in the last decade due to the 
option given by the Employees‟ Provident Fund, which gave its members the option of using their savings 
for a risk rated health insurance scheme. 4 There are currently plans to introduce a new national health 
financing scheme. As part of a strategy to improve the healthcare available to the majority of the population 
in Malaysia, the coordination between the public and private sectors is to be enhanced so that more people 
can gain access to the private sector. 5   
 
2.3. Public- private partnerships 
The private sector is being drawn into operating within the public health sector through a series of 
mechanisms. One of the most influential, in terms of redefining public and private sector relationships, are 
public-private partnerships (PPPs). This covers a wide range of possible relationships, from contracting the 
private sector to supply goods (e.g. drugs) or services (e.g. cleaning), through to arrangements where a 
private company may manage a public hospital or finance a new hospital in return for a long-term concession 
to provide services.  
 
There are three major problems that can arise with public-private partnerships and private finance initiatives.  
1. The quality of the services delivered 
2. Pay, terms and conditions for workers 
3. Length of payback terms for the public sector, which may result in long-term indebtedness of public 
sector. It also neutralises any “incentive” for the private sector to be efficient. 
 
PSIRU  University of Greenwich  www.psiru.org 
28/07/2010  Page 5 of 22  
  
2.4. Changing role of government in health care provision 
The introduction of contracting systems and public- private partnerships in the public health system has led 
to changes in the role of government in the health care system.  Moving from being a provider of health 
services, the public/ government sector has often relinquished direct control over providing health care 
services and taken on a coordinating and in some cases regulatory role.  This is sometimes described as 
moving from a “provider” to “enabler” role.   This process varies from country to country and has been 
encouraged directly by many health sector reform programmes through technical support from multilateral 
agencies. 
 
The combination over the last 20 years of underfunding in the public health care sector and the changing role 
of the government has led to changes in people‟s perception of the public sector and the private sector.  The 
introduction of user fees for government health care services has also meant that government services are 
often no longer free.  The perception in some countries is that the public sector is underfunded leading to 
lack of staff, overcrowding, long waiting times, and lack of drug supplies. This can lead to both patients and 
staff moving to the private sector.   
 
In terms of the future of public services, there are questions about what type of policies may help to 
strengthen the role of the government in the health care sector.  This includes the development of a strong 
government regulatory role, which would control the presence of the private sector within the public health 
sector.  However extensive work needs to be done to develop effective systems of regulation. 
 
2.5. Health tourism 
Medical tourism can be defined as the provision of „cost effective‟ private medical care in collaboration with 
the tourism industry for patients needing surgical and other forms of specialized treatment.6  This process is 
being facilitated by both the corporate sector involved in medical care as well as the tourism industry.  
Health ministries are also involved.  Many governments are promoting health tourism as a way of drawing in 
foreign exchange. In Asia, India, Malaysia, Singapore and the Philippines are actively promoting medical 
tourism.   
 
For example, India‟s National Health policy (2002) aims to “capitalise on the comparative cost advantage 
enjoyed by domestic health facilities in the secondary and tertiary sector, the policy will encourage the 
supply of services to patients of foreign origin on payment. The rendering of such services on payment in 
foreign exchange will be treated as „deemed exports‟ and will be made eligible for all fiscal incentives 
extended to export earnings”.7 The Apollo Group in India has already started to develop medical tourism in 
India and draws patients from Africa, Asia and the Middle East.  Another corporate group in India, the 
Escorts group, is also expanding the number of patients it treats from overseas.8 
 
The advantage that Asian countries present in medical tourism is that their prices are cheaper than private 
healthcare in either North America or Europe.  Medical tourism promotes the view that healthcare is a series 
of products that can be bought and sold.  It takes the pressure off governments to provide accessible, 
comprehensive health services for their populations.  Private healthcare providers, for example in India, are 
lobbying governments for subsidies to enable further development of medical tourism.  
 
Key points 
 Corporatisation affects the terms and conditions of health workers, their working 
conditions and health and safety 
 Health insurance is seen as essential for middle classes to access private healthcare 
 The role of government is changing from provider to regulator 
 Health tourism is a result of the increased commercialisation of healthcare and both 
public and private sectors view it as a way of earning foreign exchange 
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3. Health and Trade 
 
3.1. GATS 
The General Agreement on Trade and Services (GATS) is an international agreement aimed to further 
liberalise trade in services.  It will impact on trade and health services.  There are four modes or types of 
trade: 
1. Mode 1 Cross border supply - neither supplier nor consumer crosses a border but the service is 
delivered by mail or telecommunications  
2. Mode 2 Consumption abroad – consumers travel across a border to obtain health services 
3. Mode 3 Commercial presence or foreign direct investment – companies establish operations or make 
investments within a country 
4. Mode 4 Presence of natural persons (temporary cross-border movement of labour) – health 
professionals travel across borders to deliver health services on a temporary basis. 9 
 
Trade in health care services refers to both the import and export of health services.  The import of health 
services in this context may be seen as a way of improving health services through bringing foreign expertise 
or technology.  A country may lower barriers so that qualified health professionals can enter the country. It 
may send patients abroad for treatment. 10  The export of health services may involve facilitating health 
service suppliers who want to establish operations in other countries, using existing health care facilitates for 
“health tourism” or making it easier for an over supply of health workers to migrate temporarily.  11 
 
One of the most significant principles of the GATS agreement that has long-term implications for the health 
sector is the “exemptions for services provided in the exercise of government authority and government 
procured services”.  Services provided by government authority (local, regional or national level) or by non-
governmental bodies exercising government authority are technically exempt from GATS obligations.  
However the definition of government authority is “supplied neither on a commercial basis nor in 
competition with one or more service suppliers”.  For health care systems that have an internal market, it is 
increasingly difficult to argue that government funded health services fit this definition of government 
authority.   
 
Regulatory reform is seen as an important factor in determining how national governments will control 
multinational companies.  This will be crucial in any attempts to safeguard parts of the health sector e.g. pro-
poor policies, cross subsidisation policies, and use of profits.   Although within the GATS there is a 
recognition of the “right of Members to regulate and to introduce new regulation in the supply of services 
within their territories in order to meet national policy objectives”, the WTO Council for Trade in Services is 
also required to develop“any necessary disciplines” to ensure that regulations e.g. qualifications,   … do not 
form “unnecessary barriers”.  Lipson (2002) points out that service suppliers may challenge domestic health 
regulations, designed to promote equity, because they might restrict trade. 
 
The health sector is not a homogenous sector but is made up of several sub-sectors, e.g. insurance, medical 
supplies, pharmaceuticals, and laboratories.  GATS may affect these sub-sectors before it affects the overall 
supply of health care.  Under GATS legislation, health insurance is classified as “insurance” or “banking and 
other financial services”.  Under insurance, most commitments relating to health insurance fall under “non-
life insurance” even though there is a category of “life, accident and health insurance”.  Health insurance is 
seen as part of the financial services sector rather than the health services sector because it is one of many 
services offered by one company, is affected by regulations relating to other insurance services and requires 
access to capital markets and reinsurance.  12 13 There is a need for stronger regulation.  Eighteen countries 
have liberalised their insurance services sector.  Companies are expected to use this as a way into health care 
systems.14 This is significant for many Asian countries where insurance companies have already started to 
enter domestic markets. 
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In Asia only a few countries have made market access commitments on a major number of sectors. India has 
opened six sectors including hospital service and is the only country in the Region that has made a 
commitment in the health sector. It is under Mode 3 commercial presence. 
 
3.2. TRIPS 
In 1994, over 100 countries signed the Trade Related Aspects of Intellectual Property Rights (TRIPS) 
Agreement which began to control the way in the property rights (or ownership) of information in a global 
economy was defined and enforced.15  TRIPS sets minimum standards in copyright, trade marks, and 
industrial designs.  It has extensive implication for the development and distribution of pharmaceuticals and 
medical equipment and devices. 
 
The Doha Declaration on the TRIPS Agreement and Public Health, adopted at the Fourth Ministerial 
Conference of the WTO, held at Doha, Qatar in November 2001, was the first time that an international  
trade declaration related to public health was adopted. The declaration, while defining the relations of TRIPS 
with public health, stressed that TRIPS should be addressed as part of the wider national and international 
initiatives taken to address global health problems. The Doha Declaration provided the mandate to the WTO 
Council for TRIPS to find a solution to the problem of countries, especially those with little or no 
manufacturing capacity in the pharmaceutical sector, in making effective use of compulsory licensing. It 
decided that the least developed countries would not be obliged to implement patent protection of 
pharmaceutical products until 2016. 16  
 
In August 2003, the WTO decided to lift TRIPS restrictions on compulsory licensing for the export of 
generic medicines to countries, which are unable to manufacture them.  However, the United States has 
recently been developing a series of bi-lateral trade agreements, for example with Singapore, Thailand, that 
threaten the impact of the August 2003 agreement. This will restrict the access of developing countries to 
affordable medicines.17  Some of the restrictions cover: extending the period of time for patent protection 
beyond the 20 year period agreed in TRIPS; new provisions giving patent holders powers to block parallel 
import of drugs; new provisions blocking companies from using clinical trial data from brand name 
companies which would delay or prevent generic competition; new provisions blocking national  drug 
registration authorities from registering generic versions of drugs after the patent has expired.18 
 
 
Key points 
 Increasing emphasis on the buying and selling of health services 
 GATS commitments to health services by individual countries still limited 
 India is the main country in Asia that has GATS commitments to Mode 3 
 TRIPS agreement will have a significant impact on developments of pharmaceuticals, 
medical devices and medical equipment 
 Increasing bi-lateral agreements between the US and individual countries will 
undermine the achievement of  Doha     
 
4. Main organisational players 
 
Healthcare policies at national and local level are strongly infuenced by policies and strategies of multilateral 
and regional agencies.  The World Bank and the International Finance Corporation, the Asian Development 
Bank, and ASEAN all influence the provision of healthcare in different Asian countries through specific 
healthcare policies as well as through trade and private sector development strategies.  
 
4.1. World Bank 
The annual World Development Report can be seen as a strong indication of World Bank policy.  One of the 
most influential World Development Reports (WDR) in relation to healthcare was „Investing in Health‟ 
PSIRU  University of Greenwich  www.psiru.org 
28/07/2010  Page 8 of 22  
  
(1993) which presented strategies for providing cost-effective basic packages of public health and healthcare 
services.19 It argued that in order to deliver basic healthcare packages, the rest of the healthcare system 
would have to become self-financing. Extensive reforms and reallocation of public spending were needed to 
achieve this.   
 
Governments were recommended to adopt user fees and self-financed insurance as well as investing in local 
level health centres and community care rather than more specialised care. Privatisation of drug distribution, 
decentralisation of healthcare management and more involvement of the private sector were also highlighted. 
Government regulation of insurance and the private sector were presented as an integral part of these 
reforms.20  This report has influenced many government healthcare policies, which have often led to a 
deterioration in the quality of services and level of accessibility rather than improvements in care. 21  
 
Although essential elements of public sector reform involve the promotion and development of the private 
sector to deliver public services, the process of outsourcing and contracting out of services has been slow in 
many developing countries.  The introduction of specific private sector development strategies in the late 
1990s by multilateral financial institutions may be interpreted as an indicator of the lack of response of the 
existing private sector to the process of economic and public sector reform.  The new more targeted approach 
of formulating specific private sector development strategies aims to develop a private sector that can both 
contribute to economic growth and deliver a wide range of public services. 
 
The revised Private Sector Development (PSD) strategy, launched by the World Bank in 2002, anticipates a 
wider role for the private sector in providing health and education services.  It is anticipated that the 
International Finance Corporation (IFC), part of the World Bank Group, will increase its lending to private 
companies working in health. 22  The World Bank Group‟s Implementation Progress Report – PSD Strategy 
highlights its work so far in building up a private sector to deliver health and social services.  There are signs 
that there has been extensive debate within the World Bank about how to promotion private provision in 
health and education.  The World Bank Private Sector Advisory Services Department (PSAS) has 
commissioned research, training and operational activities and has identified that staff need technical 
assistance to develop initiatives that increase access by poor people to health and education services.  Issues 
that World Bank staff need technical assistance include how to promote competition between public and 
private providers, the development of accreditation and regulation frameworks, the design of incentive and 
subsidy schemes, and the design and awarding of contracts, especially output based aid contracting systems.  
 
Output-based aid (OBA) refers to the focus on agreed outputs that private sector providers negotiate with the 
government or public sector. Often used in relation to infrastructure projects, the responsibility for delivery is 
with the private sector provider. The World Bank Private Sector Development (PSD) strategy argues that this 
arrangement provides “competitive disciplines that ensure that the profit margins would be bid down to 
normal levels and that the subsidy would eventually be reflected in lower prices to customers or lower cost 
to taxpayers.” In reality these can be seen to be a form of concession arrangements. However, if the income 
stream from these projects is secured in order to minimise risk for the investor, the supposed advantage of 
output based aid is an illusion. The investor has no particular advantage to deliver the output more efficiently 
and effectively, because the income is the result of negotiations, not of market forces. 23 
 
The World Development Report 2004 „Services for the Poor‟ deals with the provision of services to poor 
people.  It addresses health and nutrition programmes and begins by stating that  
“Health and nutrition services are characterised by a variety of market failures; externalities 
associated with disease, asymmetrical information between professional providers and patients and 
the failure of insurance market.  These market failures – as well as a concern for equity - justify 
some form of government intervention in health”  
It argues that services fail because of a lack of accountability. It recommends that three measures will 
improve accountability: stronger client power over service delivery; strengthening people‟s voice to 
influence public spending; strengthening the compact between policy makers and providers, to protect clients 
and ensure an equitable distribution of services.  The report identifies problems of access, affordability, poor 
quality and insensitivity to client needs in relation to the supply of services.  It also adds that  
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“ensuring regular and predictable availability of qualified health staff and affordability of care 
compounds the problem of insufficient use of clinics or hospital services”.  
This is one of a number of comments in the report that implies a critical attitude to public service staff, in 
this case health workers, and this permeates the text.  There is no attempt to analyse why health staff are not 
always available and what conditions shape their behaviour. Instead, apparently simplifying changes in 
accountability relationships are presented as solutions to the problems of public services. 
   
The report recommends that „client‟ power can be strengthened by a wide range of measures some of which 
are supported by evidence of successful practice.  Some examples include:  
 Making the income of service providers depend more on the demand from poor clients   
 Encouraging people to pay providers directly for services 
 Influencing pricing, for example cross subsidising preventive and mother and child services with 
adult health care together with generic drugs 
 Demand side subsidies, which mention some of the problems of targeting  
 Co-producing health services, which is a term used to cover self-care, client involvement in health 
services and community led initiatives. 
 
Information, monitoring, enforcement and regulation are seen as essential elements to control private 
provision.  Whilst making more information available can help service users to make more informed choices 
about health care services, the focus of all these measures is on the consumption of health care.  The rights to 
health and health care are not mentioned. 
 
4.2. International Finance Corporation 
The International Finance Corporation (IFC) is part of the World Bank Group.  It describes itself as „the 
largest multilateral source of loan and equity financing for private sector projects in the developing world‟. 
24 (www.ifc.org).   
 
In 2002, the IFC in Investing in private health care sees its main role as contributing “to the financial 
protection against ill health and to strengthening of the middle class” (IFC, 2002).  The IFC states that  
“because of the structure and financing mechanisms of health care systems, (it) cannot directly 
target the poor but rather gives loans to institutions that work with the lower-middle and middle 
class groups” (IFC, 2002). 
 
In Asia, IFC investments are concentrated in high technology and hospital healthcare projects (Table 1 p.18).  
Two types of Asian companies are partners in these investments: a) specific Asian healthcare companies e.g. 
Apollo Group of India; 2) conglomerates e.g. Lopez Group, a large diversified conglomerate in the 
Philippines.  A recent loan to the Max Healthcare company in India is for the development of a range of 
healthcare facilities at primary, secondary and tertiary levels which is unusual in its focus on primary care 
facilities. 
 
4.3. Asian Development Bank 
The Asian Development Bank is a regional investment bank.  Its health policy locates health within a social 
protection framework and focuses on improving the health of the poor, women, children and indigenous 
peoples.  The Asian Development Bank also aims to support governments to “increase public investment in 
primary healthcare, facilitating private sector involvement in health and public goods”.25 
 
The Asian Development Bank wants to test “innovative approaches to the management and financing of the 
health sector” and strengthen the managerial capacity of governments, part of its support for health sector 
reform.  It has provided loans for relatively few specific health projects and these are set within the 
framework of the Asian Development Bank‟s social protection programme.26  The amounts invested in either 
healthcare or social services are relatively small with most loans being less than $20 million. Only Indonesia, 
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in 1998 during the Asian economic crisis, received two larger loans of $300 million for development 
programmes for the health and nutrition sector and the social protection sector.   
 
Health sector reform is the focus of one or two loans but other loans have gone to rural health, nutrition and 
HIV/AIDS prevention projects.  However within these broader health projects there are often some elements 
of health sector reform.  The loan for the development of rural health in Vietnam includes “interventions to 
improve affordability of services by introducing innovative health financing mechanisms” which involves a 
pilot model for voluntary rural health insurance.  A loan for capital market development in Pakistan and the 
development of financial intermediaries in Kyrgyzstan show how the ADB supports the development of the 
private sector within the broader context of social protection.27    
 
4.4. Association of South-East Asian Nations (ASEAN) 
The Association of South East Asian Nations (ASEAN) is a regional economic grouping of countries in 
Asia.  It is active in several areas of healthcare.  The ASEAN Working Group on Technical Cooperation in 
Pharmaceuticals (AWGTCP) exchanges information in such areas as drug safety; improving access to 
medicines, the Doha Declaration on the TRIPS and public health. 28 
  
4.5. World Health Organization (WHO)  
The World Health Organization, although the global UN agency with responsibility for public health, is often 
not considered as strong an influence on national healthcare systems as multilateral funding agencies such as 
the World Bank and International Monetary Fund.  One of the areas in which WHO has had to define its role 
is in relation to multilateral trading agreements.  It is developing work on the effect on health of GATS and 
other trade agreements.  In relation to TRIPS, WHO set up a Commission on Intellectual Property Rights, 
Innovation, and Public Health in February 2004.  The terms of reference of the Commission are: 
 to summarize the existing evidence on the prevalence of diseases of public health importance with an 
emphasis on those that particularly affect poor people and their social and economic impact; 
 to review the volume and distribution of existing research, development and innovative efforts 
directed at these diseases;  
 to consider the importance and effectiveness of intellectual property regimes and other incentive and 
funding mechanisms in stimulating research and the creation of new medicines and other products 
against these diseases;  
 to analyse proposals for improving the current incentive and funding regimes, including intellectual 
property rights, designed to stimulate the creation of new medicines and other products, and 
facilitate access to them, and 
 to produce concrete proposals for action by national and international stakeholders.29 
 
Although WHO has developed a wide range of policies and initiatives that aim to address many of the health 
issues that face individual countries, its resources are often limited and its is often dependent on donor 
funding.  There have also been criticisms of its relationships with private sector interests at an international 
level.  A recent research report has analysed the safeguards that have been put in place within WHO to 
control and monitor public interests in its work with the private sector.30 The report found that that although 
new safeguards had been introduced, they were not strong enough to mediate the strong conflicts of interest 
involved in working with the private sector.   
 
The report points out that the term public-private partnerships often had three meanings: 1) a policy 
framework; 2) different categories of public-private partnerships or interactions, 3) a specific public-private 
partnership.31 The umbrella use of the term makes it difficult to analyse some of the processes involved.  The 
report found that the term „conflict of interest‟ within WHO has become taboo.  Work that had been 
commissioned to help WHO staff deal with conflicts of interest had often not been used. The report made a 
series of recommendations including: that WHO abandon the partnership terminology; clarify which types of 
public-private partnerships allows for technical and conflict of interest assessment; hold a public review of 
the benefits of different global public-private health initiatives; and formulate a public disclosure policy.32  
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Unless the issue of public- private partnerships and the public interest is addressed effectively, the credibility 
of WHO will be undermined. 
 
Key points 
 World Bank – dominance of the 1993 World Development Report on national health 
policies 
  Some recognition of need for public services although the importance of health 
workers is not recognised. 
 IFC investments – hospital and healthcare infrastructure to promote the private sector 
 Asian Development Bank – addresses healthcare within social protection policy 
 WHO – increasing  work on health and trade agreements  
 Inadequately dealing with public interests with public-private sector partnerships  
5. Regional developments 
China, India and Thailand are profiled to show some of the changes that are taking place in national health 
systems in Asia.  
5.1. China 
China has been undertaking a health reform during the past two decades.  The main areas of health system 
reform are: development of community health services (CHS); the reform of the health insurance system; 
changes in regional health planning and restructuring of services; reforms to drug management.33   
In China, the health insurance system consists of two parts, the social health insurance system and 
commercial health insurance.  There are four parts to the social health insurance system: the Urban 
Employee Basic Health Insurance Scheme (UEBHIS), the Rural Cooperative Medical Scheme (RCMS), the 
Medical Aid and the Supplementary Health Insurance Scheme.  The introduction of UEBHIS, a social 
insurance scheme for urban workers, aims to address issues raised by the restructuring of enterprises and the 
increase in retired workers.  The reforms are also intended to address the escalation of costs of medical care.  
The Urban Employee Basic Health Insurance Scheme (UEBHIS), pools risks for some urban workers, 
including both public and private sector employees at city level but will not cover all the urban population. 
Those excluded include some of the poorest urban groups, for example, older people not entitled to pensions, 
working age adult not in the labour force, children and students, unemployed people not entitled to 
unemployment benefits, rural migrants who are not registered and employed.  Provinces are responsible for 
developing their own schemes and implementing them at municipal level.34   
 
The UEBHIS program is financed by premium contributions from employers (6% of the employee‟s annual 
wage) and employees (2% of their annual wage). Currently the same rate of premium is paid whatever the 
income level. The government and companies where workers used to work, pay part of the premium for 
retired workers.  The funding is split into two elements – an individual savings account and a social pool 
account. There is a ceiling on expenditure at four times annual salary.  Insurance covers treatment at 
community services as well as higher hospitals and the use of primary care facilities is encouraged by giving 
higher reimbursement rates.  To help control the costs of the social insurance scheme, Essential Drugs Lists 
and Essential Services Lists have also been developed to specify which drugs and services are covered or not 
covered by the scheme. 
 
Total contributions are divided into two parts: individual medical account and social risk pooling.  3.8% of 
the employee‟s wage goes into the individual medical account, which enrollees can only pay for outpatient 
health care expenses in public hospitals or purchasing drugs in drug stores targeted by government. The 
individual account is held by the enrollers themselves and the amount of the money in the individual account 
depends on the level of employee‟s wage.  
 
If the enrollee uses up the money saved in the individual medical account in one year, they have to pay for 
the treatment out of their own pocket.  If not, then the remaining money will automatically be transfered to 
the next financial year. 4.2% of the wage goes into the social risk pooling, which is used to cover inpatient 
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medical expenses. The social risk pooling limits its payment for each enrollee to four times the average 
annual wage of the workers in that city. Expenses exceeding the ceiling can be covered by supplementary 
insurance schemes, or be paid by the patient out-of-pocket, or be paid through purchasing commercial health 
insurance. By the end of 2002, the UEBHIS has covered about 94 million urban populations, approximately 
accounting to 19% of total urban population. 35  
 
The Chinese government is also encouraging other kinds of health insurance models, including 
supplementary health insurance, socio-medical aid and commercial health insurance. In China, there are 
about 11.2 million populations covered by commercial health insurance in 2002, about 8.6% of the total 
population.  36  
 
Since China entered the World Trade Organisation, it has started to open up its insurance market to foreign 
investment. It is expected that foreign insurance companies will provide supplementary insurance for urban 
employees, the catastrophic in-patient health insurance for non-urban residents and group health insurance 
for students. 37 As the Chinese government cuts government welfare benefits, large numbers of workers will 
have to provide for their own health insurance and pension costs.  Health insurance companies view the 
Chinese insurance market as having great potential for expansion.  The problem has been getting the 
conditions for entry right. 
 
5.2. India 
There have been extensive changes in the Indian healthcare system in the past twenty years, which have 
resulted in a greater involvement of the corporate sector in healthcare provision.  In the 1990s several state 
level governments restructured their secondary level hospitals with support from World Bank loans. The 
funds have been used to renovate buildings, purchase equipment and drugs.  Part of the restructuring 
introduced user fees to provide a source of revenue for the secondary level hospitals.38 
 
The corporate sector experienced growth during the 1980s but this was unevenly distributed among states.  
In 1973, 22.3% of total hospitals beds were in the private sector but by the early 1990s, this had increased to 
37%.39 About 65% of private sector beds are now in urban areas. The largest part of the private sector 
consists of individual private practitioners both trained and untrained, who are based in both urban and rural 
areas.  Nursing homes and hospitals are generally in the urban areas and owned by one owner or a 
partnership. 
 
There has also been an increase in imports of medical technology.  By 1998 several multinational companies 
had set up units to manufacture medical equipment, for example, ultrasounds and scanners.  Multinational 
companies either operated alone or set up joint ventures with Indian companies.  There was no public sector 
provision of equipment.  Few limits were placed on the import of equipment and the only government 
requirement was that private hospitals importing equipment should provide some services free of cost to low 
income patients.40 
 
The Apollo Group set up the first corporate hospital in 1987 in Chennai. Large business groups, for example, 
the Tata Group, involved in hospital provision before then had set up trusts which could benefit from 
charitable status rather than establish corporate entities. The Apollo group first involved non-resident Indian 
doctors into medical care investments.  Governments provided subsidised land and duty free import of 
medical equipment.  The expansion of the Apollo Group will be discussed in Section  6.2.   
 
The costs of healthcare in the corporate owned hospitals have increased and the costs of specific surgical 
procedures are often twice that of a smaller hospital or nursing home.  The increased costs are partly due to 
the costs of imported equipment.  The rising costs of corporate care have led middle and upper income 
groups to demand access to health insurance schemes that will cover the cost of healthcare.41 
 
The development of the insurance sector has also been an important step in the continued privatisation of 
healthcare.  In 1999, an insurance bill was approved which has encouraged some foreign companies to enter 
into joint ventures with domestic companies.  However, there has still been a requirement for companies to 
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invest a certain amount of capital, which has acted as a barrier to entry into the Indian market for many 
foreign insurance companies. There is still no effective system of regulation for either hospitals or health 
insurance companies. 
 
5.3. Thailand 
Thailand has an increasing older population with a decreasing young population.  There is an increasing 
incidence of non-communicable chronic diseases.  However, levels of immunisation and life expectancy 
rates are not as high as other Asian countries.42 This suggests that investment in health care facilities is being 
made in secondary care at the expense of primary health care for the majority of the population.  The 
increase in the number of Magnetic Resonance Imaging and CT scanners from 1990-1998 reflects this trend 
towards capital expenditure in both the public and private sectors.43 
 
75% of financing for public health facilities comes from public sources (including insurance) and 25% from 
private sources.  For private health facilities, 75% funding is from private sources and 25% from the public 
sector.  Private health facilities are located in urban areas.  Public health facilities dominate the rural areas.
  
By 1998, the health insurance market in Thailand had started to expand. 44 However there was no national 
policy on health insurance and insurance-related law was out of date.  Public and private health insurance 
schemes often overlap.  For instance, members of the Civil Servant Medical Benefit Scheme can opt for 
treatment in private facilities if they are prepared to co-pay.  
 
There have been debates in the last decade about the need for a new system of universal coverage.  It was 
proposed that the Voluntary Health Care programme and the Free Medical Care Programme/ Low Income 
Card Scheme were merged to form a system of universal coverage for poorer people.  In 2001, a new 
government medical plan was introduced to 44 provinces.  It was aimed at poor income groups and provided 
treatment at a set price (30 baht) per consultation.  This initiative led to an increased public concern about 
health and health insurance is expanding.  The government has a set budget that will cover 40 million 
population at 1,202 baht per person per year.  The total population of Thailand is 62 million.45    
 
In May 2002, the Commerce Ministry outlined plans to allow insurance operators to extend health and 
personal accident insurance to more patients from the government‟s medical plan.  The government called a 
meeting with insurance companies and hospitals to discuss the possibility of bringing more customers into 
the health insurance system by reducing premium changes but maintaining the quality of medical treatment. 
46  A working committee was set up to calculate standard medical charges by applying a DRG (disease-
related group) formula and so calculate a central payment price.  The committee included representatives 
from five private hospitals:  Bumrungrad, Bangkok Nursing Home, Bangkok Christian, Vichaiyudh and 
Lertsin,  along with the life and non-life insurance associations, Bupa Blue Cross and  Thai Health Insurance 
Co. 47   
 
A law on national health insurance was passed in 2002, which set up a National Health Insurance Fund 
together with policies and guidance for health insurance scheme implementation. A National Health 
Insurance Office was established as an autonomous agency, governed by a Board chaired by the Minister of 
Public Health. This is a significant development in making healthcare accessible for a large part of the 
population.   
 
Key points 
China – introduced a new system of social insurance and trying to promote a growing private 
insurance market 
India – the expansion of the corporate sector has influence the public sector. 
Thailand – also introduced a new social insurance scheme to widen access to healthcare 
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6. Multinational healthcare companies 
 
A group of multinational companies involved in health insurance and healthcare provision are outlined 
below. 
 
6.1. Allianz 
Allianz is a global insurance, banking and investment company. In 2002 the company made substantial 
losses globally and has been restructured since then. It views health insurance as an area of expansion.  
 
In Asia, it has subsidiaries in Australia, Brunei, China, Indonesia, Japan, Laos, Malaysia, Pakistan, 
Singapore, South Korea, Taiwan and Thailand.  Its Australian subsidiary is its largest in Asia. In March 
2003, Allianz launched it business in China, which is currently limited to Guang Zhou.48  The company is 
aiming to expand its business throughout China in the medium term. In India, Allianz is involved in a joint 
venture.49  Korea and Taiwan provide the largest revenues for the company in Asia. It has withdrawn from 
the Singapore insurance market because of depressed long term prospects.50 
 
6.2. Apollo hospital group 
The Apollo hospital group was set up in 1987 as one of the first corporate hospitals in India.  It has since 
expanded throughout Asia. It owns a network of 34 hospitals in several Asian countries.51 Most important, is 
the range of activities that the company has diversified into.  It has been a leader in the development of 
medical tourism in India.  In 2004, it established its first health insurance company, which is an example of a 
company expanding into both health insurance and healthcare provision. 52 The company plans to buy three 
more hospitals overseas where it will employ Indian health staff.  53 
 
In December 2004 it announced that it was negotiating a contract for medical business process outsourcing 
with a New York teaching hospital.  This will include billing and coding operations and claims processing.54    
It is also involved with telemedicine, education and training, home healthcare and hospital project 
management.  
 
6.3. BUPA 
BUPA is an example of a non-profit company set up in 1947 in the United Kingdom (UK) at the time that 
the National Health Service was established, to provide health insurance and healthcare services for privately 
insured patients.  BUPA has expanded into South East Asia in the last 15 years and recognises that its 
expansion depends on a growing middleclass demand for healthcare.  BUPA has taken advantage of the 
opportunities for private sector provision of primary care as well as expanding its health insurance activities.   
 
BUPA entered Thailand in 1996 when it joined with Blue Cross. Blue Cross was a Thai company founded 
over thirty years ago that became Blue Cross in 1985.  BUPA Blue Cross is a provident association, which 
reinvests profits into the business.  BUPA Blue Cross has between 65% and 80% of the Thai health 
insurance market.   The company has contracts with 119 hospitals and about 100 clinics.  It provides 
insurance coverage for at least 1,500 firms and 8,000 individual members.  It has offices in Bangkok, 
Pattaya, Phuket, Chiang Mai  and Nakhon Ratchasima. 55 Although BUPA Blue Cross has a large percentage 
of the health insurance market in Thailand, it is in competition with life insurance companies that also sell 
health insurance policies as part of their life packages.  
 
BUPA has been expanding into both health insurance and healthcare provision in Asia over the last few year.  
In 2001, BUPA bought Vista Healthcare in Asia which has contributed to BUPA‟s expansion in the Asia 
market.  In 2002, BUPA together with Macquarie Bank bought AXA Asia Pacific Holdings, a health 
insurance in Australia.  It is now the third largest private health insurer in Australia.  BUPA owns half the 
business.  
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6.4. Cigna 
Cigna is a US insurance multinational company, which is active in South Korea, Hong Kong and Taiwan as 
well as the United Kingdom and Spain.  It provides individual and group life insurance, accident and health 
insurance. The Cigna group also provides benefits for expatriate employees of multinational company in 
many countries.  
 
Cigna‟s health insurance products mainly provide indemnity insurance, with some products subject to 
managed care schemes. These health insurance products usually provide an alternative or supplement to 
government provision. Health insurance includes life and medical insurance products that are provided 
through group benefit programmes as well as medical insurance products that are marketed directly to 
individuals.  
 
In 2002, a year after China joined the World Trade Organisation, Cigna was the first company to receive 
formal approval from the China Insurance Regulatory Commission to enter the Chinese life insurance 
market, and the following year, it formed a joint venture to sell insurance products in Shenzhen, China. In 
2003, Cigna sold its Japanese pension operations.56 
 
6.5. Fresenius 
The main activity of the German company, Fresenius, is the manufacture of equipment and products for 
renal care.  It is a key player in the global medical devices industry.. The global medical devices industry is 
highly competitive, and manufacturing of kidney dialysis equipment has currently little scope for innovation.  
Fresenius views health care delivery as an area of potential expansion. In 1997 it began to run renal dialysis 
clinics, and health care activities are now its largest division.  It aims to „become a large international health 
care company‟ arguing that globally „due to the expected privatisation of health systems we will have good 
opportunities to build up a company that can command a leading position in the hospital field‟57. 
 
The company provides kidney dialysis equipment, products and services through three divisions.  Fresenius 
Medical Care runs 1,300 dialysis clinics worldwide. Fresenius Kabi, provides products for nutrition and 
infusion therapy, blood treatments and some outpatient care.  Fresenius ProServe, provides management 
services such as project development, consulting, and staff training to hospitals and other health facilities.  
Vamed is part of the Proserve healthcare management division of Fresenius.  It has been involved in 
planning, building and equipping hospitals in both the public and private sectors in several Asian countries, 
for example, China, Indonesia, Malaysia, Vietnam during the last decade. 58 
 
The majority of renal care patients are found in Latin America and Asia but renal care companies only treat 
5% of patients in these regions.  This is almost certainly due to a lower rate of diagnosis and more limited 
access to health services.   Type 2 diabetes is the leading cause of end-stage renal disease.  The incidence of 
type 2 diabetes is expected to increase in the coming decade, especially in China and the Indian sub-
continent. It is closely linked to increased rates of urbanisation and changing patterns of nutrition 
characterised by higher consumption of refined foods including sugars and carbohydrates.  The demand for 
renal care will increase.   
 
Fresenius has already targeted Asia as an area of expansion. In 2003, the Asia region (excluding Japan) had 
the strongest rate of growth (5.8%) with China and India contributing most to growth.  5% of the company‟s 
66,264 employees work in Asia and the region‟s revenues increased by 7%. 
 
China is currently one of the most important markets for Fresenius Kabi in the Asia-Pacific region. Two 
joint-venture companies, Sino-Swede Pharmaceutical Corporation (SSPC) and Beijing Fresenius Kabi 
Pharmaceutical (BFP), employ about 1,000 people in China. SSPC was founded in 1982 and was the first 
Chinese-Swedish joint venture.  Fresenius has owned 51% of the shares since 1998. SSPC manufactures 
infusion solutions for parental nutrition here. Fresenius owns 65% of the shares. SSPC exports products to 
Asian countries and to Europe.  Fresenius has two other subsidiaries in India and Korea. 
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6.6. Parkway Holdings 
Parkway Holdings is a multinational company based in Singapore, that operates hospitals, healthcare centres 
and laboratories in Singapore, Malaysia, Indonesia and India. It has attempted to expand into several Asian 
countries.  Tony Tan, formerly the managing director of Parkway Holdings until 1999 when he sold a 19.6% 
stake to Schroeder Capital Partners Asia, has recently returned as deputy chairman.  He outlined some future 
directions for the company.  It is expected to expand its primary healthcare network in China and Vietnam 
“where income is growing and health care service is low “ in order to get referrals for its hospitals.  There 
will also be more joint ventures e.g. with PWD Corp to provide management contracts for hospitals and 
basic health care services.  Tony Tan said “we plan to tie up with the Singapore government and see them as 
partners rather than the competition”.   59  
 
An example of a subsidiary that failed to thrive was the London Heart Hospital.  In August 2001,Parkway 
Holdings sold its only European subsidiary in the UK, the London Heart Hospital to the NHS.  The London 
private health care market is more competitive than in the rest of the UK, partly due to the competitive role 
that Private Patient Units (PPUs) of NHS hospitals play.60    
 
The corporatisation of public hospitals in Singapore and Malaysia has led to increasingly intense competition 
between public hospitals and private sector providers for private patients. Parkway sees government services 
as potential competition in its target for high income private patients, though it is also taking advantage of 
the Singapore government‟s policy of outsourcing some clinical services.   
 
Parkway has also started to run its own managed care programme (combining insurance with provision of 
care) in a joint venture with Allianz, a large European insurance company, three years ago. Parkway now has 
40,000 members in Singapore and is hoping to expand this programme to Malaysia and Indonesia in the 
future.  It is currently finding out how many members are needed to break even, and is targeting „high end‟ 
patients. Parkway views the expansion of private health insurance and private health services as 
complementary market processes.
61
   
 
The company is also investing in new hospitals in India and Brunei Darassulam. In India, Parkway Holdings 
through its unit Gleneagles Development had made a shareholders agreement with Apollo Hospitals 
Enterprise Ltd from which Apollo had acquired Duncan Industries 50% stake in Duncan Gleneagles hospital 
in Calcutta, India.  Gleneagles Development now has a 51% stake in Duncan Gleneagles and Apollo has 
49%.  Gleneagles will provide a 10 million Singapore $ loan to Duncan Gleneagles.  When this is repaid, 
Gleneagles Development will transfer 1% of its stake to Apollo and the two companies will own the new 
hospital jointly.62  The new hospital is seen as the “central health hub for Bangladesh, Myanmar and 
Bhutan”. 63  This has taken over a decade to achieve.  Gleneagles Development had initially gone into 
partnership with the Duncans group.  Duncans left the project two years ago over financial differences and 
Apollo has taken their place. 
 
Key points 
 Company expansion in both health insurance or health service provision is not always 
successful 
 China and India health insurance markets are seen as potential growth areas 
 Renal care has the potential to expand with growing rate of type 2 diabetes 
 Some healthcare companies are diversifying in to a wide range of activities 
 
 
7. Trade union action 
 
Health sector trade unions have responded to the increased commercialisation of healthcare with a variety of 
actions and strategies.  In some countries, health trade unions have taken action in alliance with other trade 
unions and civil society groups and have developed longer term coalitions to fight for improved health 
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services.  Whatever the success of specific actions, there is a continual struggle for improved health services 
and improved pay and conditions for health workers. 
 
7.1. Campaign for improved health services 
In 2004, the Bangladesh Diploma Nurses Association has been active in a campaign to improve health 
services, nursing standards and preventive health services, particularly in rural communities. The association 
developed an 11 point platform of demands which includes demands for increases in public health funding, 
for new nursing posts that would help to improve nurse to patient ratios, to establish new nursing colleges 
and improvements in pay and terms and conditions of employment.  As a result of this activity four members 
of the union have been transferred to work out of Dacca in a remote rural health centres which is seen as 
intimidation against the union.64 
 
7.2. Campaigns against privatisation and corporatisation 
The Malaysia Citizen‟s Health Initiative(CHI), which was launched in March 1998 and describes itself as an 
“informal grouping of organizations and individuals seeking to promote greater community involvement in 
healthcare reforms, and more generally in matters of health policy”.  As an alliance of trade unions and civil 
society groups, it won a campaign to strop the privatisation of public sector hospitals in Malaysia in May 
1999.   
 
The Malaysian TUC played an important role in the campaign to stop hospital privatisation by collecting 
10,000 signatures which were delivered to the Health Minister at the beginning of the campaign. CHI 
marshalled intense public pressure on the government to stop the corporatisation of state-run general 
hospitals.  The signature campaign began in late May when doctors at a state-run general hospital in Ipoh 
city, circulated a letter to the health minister expressing concern over the privatisation of general hospitals. 
Soon after, more than 80 doctors at the city's hospital had endorsed the letter. Another 80 doctors attending 
the Malaysian Medical Association's annual general meeting in Penang in May added their signatures to the 
petition.  The Malaysian Medical Association (MMA), representing 80% of Malaysia‟s doctors called for a 
moratorium on corporatisation, supported by its members.   The Malayan Nurses‟ Union, representing 
government service nurses, and the Estates Hospital Assistants Association of Malaysia supported its 
demands.  They declared “scepticism and apprehension about the benefits of corporatisation”.65 
 
In South Korea in 2002, KCTU conducted a sit-in at Jongmyo Park in Seoul and more than 5,000 union 
members paraded after the sit-in. The KCTU called for the withdrawal of privatisation plans for state-run 
enterprises and protested the introduction of a five-day working week.66  
 
 
7.3. Rights of workers and terms and conditions 
 
In June 2000, 500 ancillary workers from the laundry, catering and gardening areas at Princess Alexander 
Hospital, Queensland went on strike because of the increased use of casual and contract labour as well as 
under-staffing, high workloads and low pay.  67 
 
On 13 June 2001, South Korean health workers joined airline workers and manufacturing workers in strikes 
with demands for pay increases and an end to government-led economic restructuring that has led to 
thousands of job losses. 68 
 
On 23 May 2002, the Korean Health and Medical Workers' Union (KHMWU) launched strikes in 16 
hospitals. Two hospitals staged full-scale walkouts, while workers at 13 hospitals took part in partial strikes. 
Union members called for more staff, demanding that the distinction between full-time and part-time 
workers be abolished. 69 
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8. Conclusions 
 This is a period of rapid change in national healthcare systems.  
 National governments are reviewing how healthcare is financed which is leading to the development 
of new social insurance schemes and the encouragement of private health insurance 
 Corporatisation of healthcare institutions has a significant influence on health workers and blurs the 
lines between public and private sectors. 
 Increasing commercialisation of healthcare leads to healthcare being seen as a service that can be 
bought and sold not as an essential right for the population. 
 Trade agreements also strengthen the view of healthcare as a commodity. 
 Health insurance and healthcare provision are both seen by multinational companies are having 
potential for growth but the process of market expansion is not easy 
 Trade unions continue to struggle to maintain pay and conditions and improve working conditions. 
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Table 1: International Finance Corporation (IFC) investments in Asia) 
 
Name Loan/ total budget Project description Sponsors/ investors 
Franco-
Vietnam 
Hospital, 
Vietnam 2001 
$8.0m 
Total budget $40.0m 
A new tertiary hospital in Ho Chi Minh 
City. 
Asian Development Bank, Bank for Investment and 
Development of Vietnam, Proparco (private sector arm 
of Agence Francaise de Developpement) 
Philippines 
Asian Eye 
Institute (AEI) 
 
Total budget $4.2m 
To establish the first centre providing a 
complete range of services for diagnosis 
and management of eye diseases. 
Main sponsor : 
Lopez Group (the largest diversified conglomerate in 
the Philippines) through First Philippines Corporation 
–a holding company of the Lopez Group – and three 
other subsidiaries/ affiliates of the Lopez Group 
Wanjie Cancer 
Hospital, China 
  
$15m  
Total budget $59.0 
Expansion of cancer centre includes the 
installation of a Proton Treatment System 
(PTS) to be housed in a new 600 bed 
facility.  
Zibo Wan Jie Tumor a wholly owned subsidiary of 
Wanjie Ind Co.Ltd- a flagship company of the Wan 
Jie Group a non-state, limited liability company 
Asian Hospital, 
Philippines 
„A‟ loan $10m from 
own account 
„B‟ loan $10m from 
accounts of 
participating banks 
„C‟ loan $5 m 
convertible loan  
Total budget $91m 
To construct and operate a 247-bed private 
tertiary hospital.  
Vista Healthcare Pte.Asia Ltd 
Dr. Jorge Garcia and Ms. Evelyn Singson 
Apollo Sri 
Lanka  
Hospital 
Considering a $5m 
loan, and $1m equity/ 
quasi equity loan 
Total budget $32m 
To establish a 350-bed private hospital in 
Colombo 
Apollo Hospital Group of India. Indian Hospital 
Corporation Ltd will help to design and manage the 
project  
Duncan 
Gleneagles 
Hospital, India 
$7m IFC loan and 
equity investment 
$1m 
Total budget $29.4 
To establish a 270-bed private hospital in 
Calcutta. 
A joint venture between Duncans Goenka Group, 
India and Gleneagles Development Pte.Ltd Singapore. 
Gleneagles Management Services Pte Ltd will 
manage the hospital 
Siliom-
Gleneagles 
Hospital, 
Indonesia 
„A‟ loan $8.3m 
quasi-equity loan 
$3.6 
Total budget $48m 
To provide high-quality hospital care to 
residents of Greater Jakarta seeking private 
health care. 
Gleneagles Hospital Company is the technical partner 
with 30% ownership 
70% owned by Lippo Land, Indonesian development 
company publicly traded 
MedCen 
Samoa Ltd 
„A‟ loan $8.3m and 
quasi equity $3.6m 
Total budget $48m 
A start up business which will include 22 
private bed hospital 
IFC‟s Pacific Islands Investment facility 
Max 
Healthcare 
2003 
Total budget 
$84million 
 
To establish and operate a comprehensive 
network of healthcare facilities in New 
Delhi and its neighbouring townships, India, 
including 16 Dr. Max primary care clinics, 
five "Medcentres" (30/40-bed short-term 
stay secondary care nursing homes with 
complete range of diagnostic services), and 
two tertiary level hospitals (a 212-bed 
multi-specialty hospital and a 150 bed 
super-specialty hospital).   
 
 
Max Healthcare Institute Limited (MHIL or Max 
Healthcare), a wholly owned subsidiary of Max India 
Limited (Max) 
 
 
Source: www.ifc.org/projects/ 
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Table 2: Asian Development Bank healthcare loans 
 
Country Programme Details Date Amount Partners 
Mongolia Health sector development  
To help the Government in 
implementing health 
system reforms and 
investment that will 
improve effectiveness, 
efficiency and 
sustainability of health 
services 
Policy reforms, investments and technical 
assistance 
1997 $15.9 - 
Vietnam 
 
 
 
 
 
 
Rural health 
To provide primary and 
preventive health care to 
the poor and 
disadvantaged, including 
ethnic minorities, women 
and children, in the rural 
areas of 13 provinces of 
Viet Nam 
To improve access to health services by 
upgrading health centres in rural areas. To 
enhance the skills of health care service 
providers. To strengthen demand for 
health services through targeted 
information, education and 
communication activities, improved 
community participation and more 
equitable health financing. To support the 
Government's scheme to provide free 
health cards to the poor. To support 
preventive health care through 
strengthening of food safety infrastructure 
and behaviour change communication. 
2000 $68.3m UNFPA, 
UNICEF 
WHO 
Co-
financing 
partners 
Philippines Early childhood 
development  
The Project will develop, 
provide and promote an 
integrated set of early 
childhood development 
service delivery packages 
to address the health, 
nutrition, cognitive and 
psychosocial development 
needs of children under six 
at various stages of growth 
and development 
There are three components: (i) early 
childhood development service delivery - 
programme support for provinces and 
local government unit financing facilities 
for municipal/ city projects; (ii) support 
for service delivery; and (iii) research and 
development.  
 
1998 $24.5  
Indonesia Health and nutrition sector 
development 
Policy measures to help 
alleviate the impact of the 
crisis on the most 
vulnerable groups while 
laying the foundation for 
longer term, sustainable 
reform in health services 
delivery. 
The policy reforms concentrate on four 
broad areas: (i) maintaining access and 
equity (regional and socio-cultural), 
especially for the poor; (ii) maintaining 
quality; (iii) enhancing decentralized 
management; and (iv) improving 
efficiency 
1999 $300  
Central 
Asian 
Republics 
Asian countries in 
transition for improved 
nutrition for poor mothers 
and children 
To reduce the prevalence 
of iodine deficiency 
disorders and iron 
deficiency anaemia in 
ACT, thereby reducing 
prevalence of poverty 
To test an umbrella regional program for 
delivering micronutrient-fortified salt and 
wheat flour to the populations of 
participating Asian Countries in 
Transition (ACT), Azerbaijan, 
Kazakhstan, Kyrgyz Republic, Mongolia, 
Tajikistan, and Uzbekistan.  
 
2001 $6.85  
PSIRU  University of Greenwich  www.psiru.org 
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through raised intelligence, 
improved learning, and 
greater productivity. 
Greater 
Mekong 
Delta 
Community action for 
preventing HIV/AIDS 
Support HIV/AIDS 
prevention in strategically 
important areas for the 
transmission of HIV in the 
region 
Strengthen capacities of the national and 
local HIV authorities and selected NGOs 
for the development of community based 
prevention and care programs 
 
2001 $7.0  
Source: www.adb.org 
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